These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30723081)

  • 1. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3.
    Campbell RA; Schwertz H; Hottz ED; Rowley JW; Manne BK; Washington AV; Hunter-Mellado R; Tolley ND; Christensen M; Eustes AS; Montenont E; Bhatlekar S; Ventrone CH; Kirkpatrick BD; Pierce KK; Whitehead SS; Diehl SA; Bray PF; Zimmerman GA; Kosaka Y; Bozza PT; Bozza FA; Weyrich AS; Rondina MT
    Blood; 2019 May; 133(19):2013-2026. PubMed ID: 30723081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human keratinocyte cultures (HaCaT) can be infected by DENV, triggering innate immune responses that include IFNλ and LL37.
    López-González M; Meza-Sánchez D; García-Cordero J; Bustos-Arriaga J; Vélez-Del Valle C; Marsch-Moreno M; Castro-Jiménez T; Flores-Romo L; Santos-Argumedo L; Gutiérrez-Castañeda B; Cedillo-Barrón L
    Immunobiology; 2018 Nov; 223(11):608-617. PubMed ID: 30007822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus induces interferon-β by activating RNA sensing pathways in megakaryocytes.
    Arya RP; Lahon A; Patel AK
    Immunol Lett; 2021 Aug; 236():31-36. PubMed ID: 34111476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFITM3 affects the level of antibody response after influenza vaccination.
    Lei N; Li Y; Sun Q; Lu J; Zhou J; Li Z; Liu L; Guo J; Qin K; Wang H; Zhao J; Li C; Sun L; Wang D; Zhao Z; Shu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):976-987. PubMed ID: 32321380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection.
    Zhu X; He Z; Yuan J; Wen W; Huang X; Hu Y; Lin C; Pan J; Li R; Deng H; Liao S; Zhou R; Wu J; Li J; Li M
    Cell Microbiol; 2015 Jan; 17(1):105-18. PubMed ID: 25131332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity to dengue virus infection and subversion of antiviral responses.
    Green AM; Beatty PR; Hadjilaou A; Harris E
    J Mol Biol; 2014 Mar; 426(6):1148-60. PubMed ID: 24316047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.
    Sun X; Zeng H; Kumar A; Belser JA; Maines TR; Tumpey TM
    J Virol; 2016 Dec; 90(24):11157-11167. PubMed ID: 27707929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
    John SP; Chin CR; Perreira JM; Feeley EM; Aker AM; Savidis G; Smith SE; Elia AE; Everitt AR; Vora M; Pertel T; Elledge SJ; Kellam P; Brass AL
    J Virol; 2013 Jul; 87(14):7837-52. PubMed ID: 23658454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Dengue Virus Circumvents Innate Immunity.
    Kao YT; Lai MMC; Yu CY
    Front Immunol; 2018; 9():2860. PubMed ID: 30564245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Cellular Heterogeneity and an Immune Subpopulation of Human Megakaryocytes.
    Liu C; Wu D; Xia M; Li M; Sun Z; Shen B; Liu Y; Jiang E; Wang H; Su P; Shi L; Xiao Z; Zhu X; Zhou W; Wang Q; Gao X; Cheng T; Zhou J
    Adv Sci (Weinh); 2021 Aug; 8(15):e2100921. PubMed ID: 34042332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus.
    Yount JS; Karssemeijer RA; Hang HC
    J Biol Chem; 2012 Jun; 287(23):19631-41. PubMed ID: 22511783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFITM3: How genetics influence influenza infection demographically.
    Wellington D; Laurenson-Schafer H; Abdel-Haq A; Dong T
    Biomed J; 2019 Feb; 42(1):19-26. PubMed ID: 30987701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2'-O-Methylation Mutant.
    Schmid B; Rinas M; Ruggieri A; Acosta EG; Bartenschlager M; Reuter A; Fischl W; Harder N; Bergeest JP; Flossdorf M; Rohr K; Höfer T; Bartenschlager R
    PLoS Pathog; 2015 Dec; 11(12):e1005345. PubMed ID: 26720415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3.
    Jiang LQ; Xia T; Hu YH; Sun MS; Yan S; Lei CQ; Shu HB; Guo JH; Liu Y
    Cell Mol Immunol; 2018 Sep; 15(9):858-867. PubMed ID: 28435159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsRNA-stimulated human lung epithelial cells.
    Li Y; Xie J; Wu S; Xia J; Zhang P; Liu C; Zhang P; Huang X
    PLoS One; 2013; 8(1):e55108. PubMed ID: 23372823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses.
    Wollner CJ; Richner M; Hassert MA; Pinto AK; Brien JD; Richner JM
    J Virol; 2021 May; 95(12):. PubMed ID: 33762420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
    Feeley EM; Sims JS; John SP; Chin CR; Pertel T; Chen LM; Gaiha GD; Ryan BJ; Donis RO; Elledge SJ; Brass AL
    PLoS Pathog; 2011 Oct; 7(10):e1002337. PubMed ID: 22046135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Variant
    Villanueva-Aguilar ME; Rizo-de-la-Torre LDC; Granados-Muñiz MDP; Montoya-Fuentes A; Montoya-Fuentes H
    Viral Immunol; 2023 Apr; 36(3):229-237. PubMed ID: 36730734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.